BACH1 and sarcoma: Patients with low BACH1 expression in groups like KIRP (Kidney renal papillary cell carcinoma, p = 0.0011), LGG (lower grade glioblastoma, p < 0.001), LIHC (Liver hepatocellular carcinoma, p = 0.01), PAAD (Pancreatic adenocarcinoma, p = 0.034), SARC (Sarcoma, p < 0.001), THCA (Thyroid carcinoma, p = 0.052) had a better prognosis than that with high BACH1 expression.